Role of the Fatty Acid Binding Proteins in Cardiovascular Diseases: A Systematic Review
Abstract
:1. Introduction
2. Cardiovascular Disease
2.1. The Burden of Cardiovascular Disease
2.2. Risk Factors
2.3. Causes of CVD
2.4. CVD and The Metabolic Syndrome
3. The Endothelium and Its Roles in Cardiovascular Disease
3.1. The Endothelium
3.2. Role of Endothelium in CVD
3.3. Endothelial Fatty Acids Metabolism
4. Fatty Acid Binding Proteins
4.1. FABP3
4.2. FABP4 and 5
4.3. FABP in Endothelium
5. Closing Remarks
Author Contributions
Funding
Conflicts of Interest
References
- Shi, A.; Tao, Z.; Wei, P.; Zhao, J. Epidemiological aspects of heart diseases. Exp. Ther. Med. 2016, 12, 1645–1650. [Google Scholar] [CrossRef] [PubMed]
- Gaziano, T.; Reddy, K.S.; Paccaud, F.; Horton, S.; Chaturvedi, V. Cardiovascular Disease. In Disease Control Priorities in Developing Countries; Jamison, D.T., Breman, J.G., Measham, A.R., Alleyne, G., Claeson, M., Evans, D.B., Jha, P., Mills, A., Musgrove, P., Eds.; World Bank: Washington, DC, USA, 2006; ISBN 978-0-8213-6179-5. [Google Scholar]
- Sanchis-Gomar, F.; Perez-Quilis, C.; Leischik, R.; Lucia, A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann. Transl. Med. 2016, 4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schultz, W.M.; Kelli, H.M.; Lisko, J.C.; Varghese, T.; Shen, J.; Sandesara, P.; Quyyumi, A.A.; Taylor, H.A.; Gulati, M.; Harold, J.G.; et al. Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions. Circulation 2018, 137, 2166–2178. [Google Scholar] [CrossRef] [PubMed]
- Virani, S.S.; Alonso, A.; Benjamin, E.J.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Chang, A.R.; Cheng, S.; Delling, F.N.; et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation 2020, 141, e139–e596. [Google Scholar] [CrossRef] [PubMed]
- Dunbar, S.B.; Khavjou, O.A.; Bakas, T.; Hunt, G.; Kirch, R.A.; Leib, A.R.; Morrison, R.S.; Poehler, D.C.; Roger, V.L.; Whitsel, L.P. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association. Circulation 2018, 137, e558–e577. [Google Scholar] [CrossRef] [PubMed]
- Messner, B.; Bernhard, D. Smoking and Cardiovascular Disease. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 509–515. [Google Scholar] [CrossRef] [Green Version]
- Puddey, I.; Zilkens, R.; Croft, K.; Beilin, L. Alcohol and Endothelial Function: A Brief Review. Clin. Exp. Pharmacol. Physiol. 2001, 28, 1020–1024. [Google Scholar] [CrossRef]
- Jousilahti, P.; Vartiainen, E.; Tuomilehto, J.; Puska, P. Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease. Circulation 1999, 99, 1165–1172. [Google Scholar] [CrossRef] [Green Version]
- Jani, B.; Rajkumar, C. Ageing and vascular ageing. Postgrad Med. J. 2006, 82, 357–362. [Google Scholar] [CrossRef]
- Mosca, L.; Barrett-Connor, E.; Wenger, N.K. Sex/gender differences in cardiovascular disease prevention: What a difference a decade makes. Circulation 2011, 124, 2145–2154. [Google Scholar] [CrossRef] [Green Version]
- Kannel, W.B.; Wilson, P.W.F. Risk Factors That Attenuate the Female Coronary Disease Advantage. Arch. Intern. Med. 1995, 155, 57–61. [Google Scholar] [CrossRef]
- Mehta, L.S.; Beckie, T.M.; DeVon, H.A.; Grines, C.L.; Krumholz, H.M.; Johnson, M.N.; Lindley, K.J.; Vaccarino, V.; Wang, T.Y.; Watson, K.E.; et al. Acute Myocardial Infarction in Women. Circulation 2016, 133, 916–947. [Google Scholar] [CrossRef] [PubMed]
- Khan, N.A.; Daskalopoulou, S.S.; Karp, I.; Eisenberg, M.J.; Pelletier, R.; Tsadok, M.A.; Dasgupta, K.; Norris, C.M.; Pilote, L.; for the GENESIS PRAXY Team. Sex Differences in Acute Coronary Syndrome Symptom Presentation in Young Patients. JAMA Intern. Med. 2013, 173, 1863–1871. [Google Scholar] [CrossRef] [PubMed]
- Hajar, R. Genetics in Cardiovascular Disease. Heart Views 2020, 21, 55–56. [Google Scholar] [CrossRef] [PubMed]
- Burchard, E.G.; Ziv, E.; Coyle, N.; Gomez, S.L.; Tang, H.; Karter, A.J.; Mountain, J.L.; Pérez-Stable, E.J.; Sheppard, D.; Risch, N. The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice. N. Engl. J. Med. 2003, 348, 1170–1175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Psaltopoulou, T.; Hatzis, G.; Papageorgiou, N.; Androulakis, E.; Briasoulis, A.; Tousoulis, D. Socioeconomic status and risk factors for cardiovascular disease: Impact of dietary mediators. Hell. J. Cardiol. 2017, 58, 32–42. [Google Scholar] [CrossRef]
- Soliman, G.A. Dietary Fiber, Atherosclerosis, and Cardiovascular Disease. Nutrients 2019, 11, 1155. [Google Scholar] [CrossRef] [Green Version]
- Origin of atherosclerosis in childhood and adolescence. Am. J. Clin. Nutr. 2000, 72, 1307s–1315s. [CrossRef]
- Rafieian-Kopaei, M.; Setorki, M.; Doudi, M.; Baradaran, A.; Nasri, H. Atherosclerosis: Process, indicators, risk factors and new hopes. Int. J. Prev. Med. 2014, 5, 927–946. [Google Scholar]
- Bergheanu, S.C.; Bodde, M.C.; Jukema, J.W. Pathophysiology and treatment of atherosclerosis: Current view and future perspective on lipoprotein modification treatment. Neth. Heart J. 2017, 25, 231–242. [Google Scholar] [CrossRef] [Green Version]
- Ye, D.; Lammers, B.; Zhao, Y.; Meurs, I.; van Berkel, T.J.C.; van Eck, M. ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis. Curr. Drug Targets 2011, 12, 647–660. [Google Scholar] [CrossRef]
- Alshehri, A.M. Metabolic syndrome and cardiovascular risk. J. Fam. Community Med. 2010, 17, 73–78. [Google Scholar] [CrossRef]
- Al-Goblan, A.S.; Al-Alfi, M.A.; Khan, M.Z. Mechanism linking diabetes mellitus and obesity. Diabetes Metab. Syndr. Obes. 2014, 7, 587–591. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ballantyne, C.M.; Hoogeveen, R.C.; McNeill, A.M.; Heiss, G.; Schmidt, M.I.; Duncan, B.B.; Pankow, J.S. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int. J. Obes. 2008, 32 (Suppl. 2), S21–S24. [Google Scholar] [CrossRef] [Green Version]
- Félétou, M. The Endothelium: Part. 1: Multiple Functions of the Endothelial Cells—Focus on Endothelium-Derived Vasoactive Mediators; Integrated Systems Physiology: From Molecule to Function to Disease; Morgan & Claypool Life Sciences: San Rafael, CA, USA, 2011. [Google Scholar]
- Fischer, C.; Schneider, M.; Carmeliet, P. Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb. Exp. Pharmacol. 2006, 157–212. [Google Scholar] [CrossRef]
- Kalebic, T.; Garbisa, S.; Glaser, B.; Liotta, L.A. Basement membrane collagen: Degradation by migrating endothelial cells. Science 1983, 221, 281–283. [Google Scholar] [CrossRef] [PubMed]
- Jaffe, E.A. Cell biology of endothelial cells. Hum. Pathol. 1987, 18, 234–239. [Google Scholar] [CrossRef]
- Aird, W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 2007, 100, 158–173. [Google Scholar] [CrossRef]
- Bennett, H.S.; Luft, J.H.; Hampton, J.C. Morphological classifications of vertebrate blood capillaries. Am. J. Physiol. 1959, 196, 381–390. [Google Scholar] [CrossRef] [Green Version]
- Velnar, T.; Gradisnik, L. Tissue Augmentation in Wound Healing: The Role of Endothelial and Epithelial Cells. Med. Arch. 2018, 72, 444–448. [Google Scholar] [CrossRef]
- Pober, J.S.; Min, W.; Bradley, J.R. Mechanisms of endothelial dysfunction, injury, and death. Annu. Rev. Pathol. 2009, 4, 71–95. [Google Scholar] [CrossRef] [PubMed]
- Cahill, P.A.; Redmond, E.M. Vascular endothelium—Gatekeeper of vessel health. Atherosclerosis 2016, 248, 97–109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Halcox, J.P.J. Chapter 66—Endothelial Dysfunction. In Primer on the Autonomic Nervous System, 3rd ed.; Robertson, D., Biaggioni, I., Burnstock, G., Low, P.A., Paton, J.F.R., Eds.; Academic Press: San Diego, CA, USA, 2012; pp. 319–324. ISBN 978-0-12-386525-0. [Google Scholar]
- Hadi, H.A.R.; Carr, C.S.; Al Suwaidi, J. Endothelial dysfunction: Cardiovascular risk factors, therapy, and outcome. Vasc. Health Risk Manag. 2005, 1, 183–198. [Google Scholar]
- Davignon, J.; Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109, III27–III32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kuo, A.; Lee, M.Y.; Sessa, W.C. Lipid Droplet Biogenesis and Function in the Endothelium. Circ. Res. 2017, 120, 1289–1297. [Google Scholar] [CrossRef] [PubMed]
- Wei, X.; Schneider, J.G.; Shenouda, S.M.; Lee, A.; Towler, D.A.; Chakravarthy, M.V.; Vita, J.A.; Semenkovich, C.F. De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. J. Biol. Chem. 2011, 286, 2933–2945. [Google Scholar] [CrossRef] [Green Version]
- Hagberg, C.E.; Falkevall, A.; Wang, X.; Larsson, E.; Huusko, J.; Nilsson, I.; van Meeteren, L.A.; Samen, E.; Lu, L.; Vanwildemeersch, M.; et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 2010, 464, 917–921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schoors, S.; Bruning, U.; Missiaen, R.; Queiroz, K.C.; Borgers, G.; Elia, I.; Zecchin, A.; Cantelmo, A.R.; Christen, S.; Goveia, J.; et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 2015, 520, 192–197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Patella, F.; Schug, Z.T.; Persi, E.; Neilson, L.J.; Erami, Z.; Avanzato, D.; Maione, F.; Hernandez-Fernaud, J.R.; Mackay, G.; Zheng, L.; et al. Proteomics-based metabolic modeling reveals that fatty acid oxidation (FAO) controls endothelial cell (EC) permeability. Mol. Cell. Proteom. 2015, 14, 621–634. [Google Scholar] [CrossRef] [Green Version]
- Xiong, J.; Kawagishi, H.; Yan, Y.; Liu, J.; Wells, Q.S.; Edmunds, L.R.; Fergusson, M.M.; Yu, Z.-X.; Rovira, I.I.; Brittain, E.L.; et al. A Metabolic Basis for Endothelial-to-Mesenchymal Transition. Mol. Cell 2018, 69, 689–698.e7. [Google Scholar] [CrossRef] [Green Version]
- Glatzel, D.K.; Koeberle, A.; Pein, H.; Löser, K.; Stark, A.; Keksel, N.; Werz, O.; Müller, R.; Bischoff, I.; Fürst, R. Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition. J. Lipid Res. 2018, 59, 298–311. [Google Scholar] [CrossRef] [Green Version]
- Mitchell, J.A.; Ahmetaj-Shala, B.; Kirkby, N.S.; Wright, W.R.; Mackenzie, L.S.; Reed, D.M.; Mohamed, N. Role of prostacyclin in pulmonary hypertension. Glob. Cardiol. Sci. Pract. 2014, 2014, 382–393. [Google Scholar] [CrossRef] [Green Version]
- Yui, K.; Imataka, G.; Nakamura, H.; Ohara, N.; Naito, Y. Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders. Curr. Neuropharmacol. 2015, 13, 776–785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Makki, K.; Froguel, P.; Wolowczuk, I. Adipose tissue in obesity-related inflammation and insulin resistance: Cells, cytokines, and chemokines. ISRN Inflamm. 2013, 2013, 139239. [Google Scholar] [CrossRef] [Green Version]
- Furuhashi, M.; Fucho, R.; Görgün, C.Z.; Tuncman, G.; Cao, H.; Hotamisligil, G.S. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J. Clin. Investig. 2008, 118, 2640–2650. [Google Scholar] [CrossRef] [Green Version]
- Maeda, K.; Uysal, K.T.; Makowski, L.; Görgün, C.Z.; Atsumi, G.; Parker, R.A.; Brüning, J.; Hertzel, A.V.; Bernlohr, D.A.; Hotamisligil, G.S. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 2003, 52, 300–307. [Google Scholar] [CrossRef] [Green Version]
- Chmurzyńska, A. The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism. J. Appl. Genet. 2006, 47, 39–48. [Google Scholar] [CrossRef] [PubMed]
- Schroeder, F.; Jolly, C.A.; Cho, T.H.; Frolov, A. Fatty acid binding protein isoforms: Structure and function. Chem. Phys. Lipids 1998, 92, 1–25. [Google Scholar] [CrossRef]
- Storch, J.; Thumser, A.E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 2010, 285, 32679–32683. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Furuhashi, M.; Hotamisligil, G.S. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 2008, 7, 489–503. [Google Scholar] [CrossRef] [Green Version]
- Hughes, M.L.R.; Liu, B.; Halls, M.L.; Wagstaff, K.M.; Patil, R.; Velkov, T.; Jans, D.A.; Bunnett, N.W.; Scanlon, M.J.; Porter, C.J.H. Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner. J. Biol. Chem. 2015, 290, 13895–13906. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Coe, N.R.; Bernlohr, D.A. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta 1998, 1391, 287–306. [Google Scholar] [CrossRef]
- Wang, Y. Small lipid-binding proteins in regulating endothelial and vascular functions: Focusing on adipocyte fatty acid binding protein and lipocalin-2. Br. J. Pharmacol. 2012, 165, 603–621. [Google Scholar] [CrossRef] [Green Version]
- Vassileva, G.; Huwyler, L.; Poirier, K.; Agellon, L.B.; Toth, M.J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J. 2000, 14, 2040–2046. [Google Scholar] [CrossRef]
- Schug, T.T.; Berry, D.C.; Shaw, N.S.; Travis, S.N.; Noy, N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129, 723–733. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stanley, W.C.; Recchia, F.A.; Lopaschuk, G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 2005, 85, 1093–1129. [Google Scholar] [CrossRef]
- Zanotti, G. Muscle fatty acid-binding protein. Biochim. Biophys. Acta 1999, 1441, 94–105. [Google Scholar] [CrossRef]
- Motojima, K. Differential effects of PPARalpha activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver. Int. J. Biochem. Cell Biol. 2000, 32, 1085–1092. [Google Scholar] [CrossRef]
- Karbek, B.; Özbek, M.; Bozkurt, N.C.; Ginis, Z.; Güngünes, A.; Ünsal, I.Ö.; Cakal, E.; Delibası, T. Heart-type fatty acid binding protein (H-FABP): Relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism. Cardiovasc. Diabetol. 2011, 10, 37. [Google Scholar] [CrossRef] [Green Version]
- Binas, B.; Danneberg, H.; McWhir, J.; Mullins, L.; Clark, A.J. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 1999, 13, 805–812. [Google Scholar] [CrossRef] [Green Version]
- Zhuang, L.; Li, C.; Chen, Q.; Jin, Q.; Wu, L.; Lu, L.; Yan, X.; Chen, K. Fatty acid-binding protein 3 contributes to ischemic heart injury by regulating cardiac myocyte apoptosis and MAPK pathways. Am. J. Physiol. Heart Circ. Physiol. 2019, 316, H971–H984. [Google Scholar] [CrossRef] [PubMed]
- Thygesen, K.; Alpert, J.S.; Jaffe, A.S.; Simoons, M.L.; Chaitman, B.R.; White, H.D.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol. 2012, 60, 1581–1598. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Braunwald, E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation 1989, 79, 441–444. [Google Scholar] [CrossRef] [Green Version]
- Jaffe, A.S. Chasing troponin: How low can you go if you can see the rise? J. Am. Coll. Cardiol. 2006, 48, 1763–1764. [Google Scholar] [CrossRef] [Green Version]
- Glatz, J.F.; Kleine, A.H.; van Nieuwenhoven, F.A.; Hermens, W.T.; van Dieijen-Visser, M.P.; van der Vusse, G.J. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br. Heart J. 1994, 71, 135–140. [Google Scholar] [CrossRef] [Green Version]
- Knowlton, A.A.; Apstein, C.S.; Saouf, R.; Brecher, P. Leakage of heart fatty acid binding protein with ischemia and reperfusion in the rat. J. Mol. Cell. Cardiol. 1989, 21, 577–583. [Google Scholar] [CrossRef]
- Haastrup, B.; Gill, S.; Kristensen, S.R.; Jørgensen, P.J.; Glatz, J.F.; Haghfelt, T.; Hørder, M. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without St segment elevation. Cardiology 2000, 94, 254–261. [Google Scholar] [CrossRef] [PubMed]
- Syed, M.H.; Zamzam, A.; Khan, H.; Singh, K.; Forbes, T.L.; Rotstein, O.; Abdin, R.; Eikelboom, J.; Qadura, M. Fatty acid binding protein 3 is associated with peripheral arterial disease. JVS Vasc. Sci. 2020. [Google Scholar] [CrossRef]
- Furuhashi, M.; Saitoh, S.; Shimamoto, K.; Miura, T. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin. Med. Insights Cardiol. 2014, 8, 23–33. [Google Scholar] [CrossRef]
- Shum, B.O.V.; Mackay, C.R.; Gorgun, C.Z.; Frost, M.J.; Kumar, R.K.; Hotamisligil, G.S.; Rolph, M.S. The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J. Clin. Investig. 2006, 116, 2183–2192. [Google Scholar] [CrossRef] [Green Version]
- Makowski, L.; Hotamisligil, G.S. The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr. Opin. Lipidol. 2005, 16, 543–548. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Coe, N.R.; Simpson, M.A.; Bernlohr, D.A. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J. Lipid Res. 1999, 40, 967–972. [Google Scholar] [PubMed]
- Hotamisligil, G.S.; Johnson, R.S.; Distel, R.J.; Ellis, R.; Papaioannou, V.E.; Spiegelman, B.M. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996, 274, 1377–1379. [Google Scholar] [CrossRef]
- Uysal, K.T.; Scheja, L.; Wiesbrock, S.M.; Bonner-Weir, S.; Hotamisligil, G.S. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 2000, 141, 3388–3396. [Google Scholar] [CrossRef] [PubMed]
- Boord, J.B.; Maeda, K.; Makowski, L.; Babaev, V.R.; Fazio, S.; Linton, M.F.; Hotamisligil, G.S. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1686–1691. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xu, A.; Wang, Y.; Xu, J.Y.; Stejskal, D.; Tam, S.; Zhang, J.; Wat, N.M.S.; Wong, W.K.; Lam, K.S.L. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 2006, 52, 405–413. [Google Scholar] [CrossRef] [PubMed]
- Llaverias, G.; Noé, V.; Peñuelas, S.; Vázquez-Carrera, M.; Sánchez, R.M.; Laguna, J.C.; Ciudad, C.J.; Alegret, M. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem. Biophys. Res. Commun. 2004, 318, 265–274. [Google Scholar] [CrossRef] [PubMed]
- Makowski, L.; Brittingham, K.C.; Reynolds, J.M.; Suttles, J.; Hotamisligil, G.S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J. Biol. Chem. 2005, 280, 12888–12895. [Google Scholar] [CrossRef] [Green Version]
- Simpson, M.A.; LiCata, V.J.; Ribarik Coe, N.; Bernlohr, D.A. Biochemical and biophysical analysis of the intracellular lipid binding proteins of adipocytes. Mol. Cell. Biochem. 1999, 192, 33–40. [Google Scholar] [CrossRef]
- Makowski, L.; Boord, J.B.; Maeda, K.; Babaev, V.R.; Uysal, K.T.; Morgan, M.A.; Parker, R.A.; Suttles, J.; Fazio, S.; Hotamisligil, G.S.; et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 2001, 7, 699–705. [Google Scholar] [CrossRef] [Green Version]
- Hertzel, A.V.; Bennaars-Eiden, A.; Bernlohr, D.A. Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells. J. Lipid Res. 2002, 43, 2105–2111. [Google Scholar] [CrossRef] [Green Version]
- Owada, Y.; Suzuki, I.; Noda, T.; Kondo, H. Analysis on the phenotype of E-FABP-gene knockout mice. Mol. Cell. Biochem. 2002, 239, 83–86. [Google Scholar] [CrossRef]
- Xu, H.; Barnes, G.T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C.J.; Sole, J.; Nichols, A.; Ross, J.S.; Tartaglia, L.A.; et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Investig. 2003, 112, 1821–1830. [Google Scholar] [CrossRef] [PubMed]
- Cao, H.; Maeda, K.; Gorgun, C.Z.; Kim, H.-J.; Park, S.-Y.; Shulman, G.I.; Kim, J.K.; Hotamisligil, G.S. Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice. Diabetes 2006, 55, 1915–1922. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boord, J.B.; Maeda, K.; Makowski, L.; Babaev, V.R.; Fazio, S.; Linton, M.F.; Hotamisligil, G.S. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 2004, 110, 1492–1498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maeda, K.; Cao, H.; Kono, K.; Gorgun, C.Z.; Furuhashi, M.; Uysal, K.T.; Cao, Q.; Atsumi, G.; Malone, H.; Krishnan, B.; et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 2005, 1, 107–119. [Google Scholar] [CrossRef] [Green Version]
- Zamzam, A.; Syed, M.H.; Greco, E.; Wheatcroft, M.; Jain, S.; Khan, H.; Singh, K.K.; Forbes, T.L.; Rotstein, O.; Abdin, R.; et al. Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients. J. Clin. Med. 2020, 9, 2843. [Google Scholar] [CrossRef] [PubMed]
- Theodorou, K.; Boon, R.A. Endothelial Cell Metabolism in Atherosclerosis. Front. Cell Dev. Biol. 2018, 6, 82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xu, J.; Dang, Y.; Ren, Y.R.; Liu, J.O. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc. Natl. Acad. Sci. USA 2010, 107, 4764–4769. [Google Scholar] [CrossRef] [Green Version]
- Antohe, F.; Popov, D.; Radulescu, L.; Simionescu, N.; Börchers, T.; Spener, F.; Simionescu, M. Heart microvessels and aortic endothelial cells express the 15 kDa heart-type fatty acid-binding proteins. Eur. J. Cell Biol. 1998, 76, 102–109. [Google Scholar] [CrossRef]
- Yu, C.-W.; Liang, X.; Lipsky, S.; Karaaslan, C.; Kozakewich, H.; Hotamisligil, G.S.; Bischoff, J.; Cataltepe, S. Dual role of fatty acid-binding protein 5 on endothelial cell fate: A potential link between lipid metabolism and angiogenic responses. Angiogenesis 2016, 19, 95–106. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Masouyé, I.; Hagens, G.; Van Kuppevelt, T.H.; Madsen, P.; Saurat, J.H.; Veerkamp, J.H.; Pepper, M.S.; Siegenthaler, G. Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ. Res. 1997, 81, 297–303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nguyen, H.C.; Qadura, M.; Singh, K.K. Role of the Fatty Acid Binding Proteins in Cardiovascular Diseases: A Systematic Review. J. Clin. Med. 2020, 9, 3390. https://doi.org/10.3390/jcm9113390
Nguyen HC, Qadura M, Singh KK. Role of the Fatty Acid Binding Proteins in Cardiovascular Diseases: A Systematic Review. Journal of Clinical Medicine. 2020; 9(11):3390. https://doi.org/10.3390/jcm9113390
Chicago/Turabian StyleNguyen, Hien C., Mohammad Qadura, and Krishna K. Singh. 2020. "Role of the Fatty Acid Binding Proteins in Cardiovascular Diseases: A Systematic Review" Journal of Clinical Medicine 9, no. 11: 3390. https://doi.org/10.3390/jcm9113390